16 June

Novel therapeutic alternative to oral anticoagulation therapy in atrial fibrillation - Watchman LAA closure device (Hall Omega 2)

Chairperson: Prof. Pekka Raatikainen (Tampere Heart center, Finland)

17:00 - 17:05 Introduction and objectives
17:05 - 17:20 High bleeding risk in atrial fibrillation - new therapeutic options
Prof. Juhani Airaksinen, Turku University hospital, Finland
17:20 - 17:45 Evidence based alternative to oral anticoagulation in atrial   fibrillation - the Watchman device
Dr. Sven Möbius-Winkler, Universitat Leipzig Herzzentrum, Germany
17:45 - 17:55 Patient Case – Watchman implantation
Dr. Inga Narbute, Stradini University hospital Riga, Latvia
17:55 - 18:00 Take home message
Prof. Pekka Raatikainen,Tampere Heart center, Finland

Role of energy metabolism correction in the treatment of coronary heart disease (Hall Alfa)

Chairpersons: A. Erglis (Latvia), I. Kalvinsh (Latvia)

17:00 - 17:30  Efficacy of metabolic modulators in ischemic heart disease
  I. Kalvinsh
17:30 – 18:00 Partial fatty acid oxydation inhibition  improves the exercise tolerance: the Mildronate trials
 V. Dzerve
18:00 – 18:30 Efficacy corectors - what we know about their clinical implication. Mildronate
A. Erglis